1lshak K, Baptista A, Bianchi L, et al. Histological grading and staging of chronic hepatitis[ J]. J Hepatol, 1995,22:696-699.
2Perrone G, Santini D, Vincenzi B, et al. COX-2 expression in DCIS: correlation with VEGF, HER-2/neu, prognostic molecular markers and clinicopathological features [ J ]. Histopathology,2005,46:561 -568.
3Cheng J, lmanishi H, lijima H, et al. Expression of cyclooxygenase 2 and cytosolic phosphlipase A (2) in the liver tissue of patients with chronic hepatitis and liver cirrhosis [ J ]. Hepatol Res,2002,23 : 185 - 195.
5Tabemero A, Schneider F, Potenza M A, et al. COX-2 and inducible nitric oxide synthase in omental arteries harvested from pateints with severe liver disease: immuno-localization and influence on vascular tone[ J]. Intensive Care Med, 2003,29:262 -270.
7Oliveira V M, Piato S, Silva M A L G. Correlation of COX-2 and aromatase immunohistochemical expression in invasive ductal carcinoma,ductal carcinoma in situ, and adjacent normal epithelium[ J]. Breast Cancer Res Treat, 2006,95:235 -241.
8Cheng A S L, Chan H L Y, Leung W K, et al. Expression of HBx and COX-2 in chronic hepatitis B, cirrhosis and hepatocellular carcinoma: implication of HBx in upregulation of COX-2 [ J ]. Mod Pathol, 2004,17 : 1169 - 1179.
9Mohammed N A, EL-Aleem S A, EL-Hafiz H A, et al. Distribution of constitutive ( COX-1 ) and inducible (COX-2) cyclooxygenase in postviral human liver cirrhosis: a possible role for COX-2 in the pathogenesis of liver cirrhosis[ J]. J Clin Pathol, 2004,54 :350 - 354.
10Giambartolomei S, Artini M, Almerighi C, et al. Nonsteroidal anti-inflammatory drug metabolism potentiates interferon alfa signaling by increasing STAT1 phosphorylation[ J]. Hepatology, 1999,30:510 -516.
2[1]DeWitt DL. Prostaglandin and peroxide synthase:regulation of enzyme expression[J]. Biochim Biophys Acta, 1991,1083 (2):121-134.
3[2]YoKoyama C, Tanabe T. Cloning of human gene encoding prostaglandin endoperoxide synthase and primary structure of the enzyme [J]. Biochem Bioghys Res Comm un, 1989,165 ( 2 ):888-894.
4[3]Ding XZ,Hennig R,Adrian TE. Lipoxygenase and cyclooxygenase metabolism:new insights in treatment and chemoprevention of pancreatic cancer [J]. Mol Cancer, 2003,7 ( 1 ): 10.
6[6]Singer Ⅱ,Kawka DW,Schloemann S,et al. Cyclooxygenase 2 is induced in colonic epithelial cells in inflammatory bowel disease[J]. Gastroenterology, 1998,115 (2): 297-306.
7[8]Sano H,Kawchito Y,Wilder RL,et al. Expression of cyclooxygenase-1 and -2 in human colorectal cancer [J]. Cancer Res,1995,55 (17): 3785-3789.
8[10]Nanji AA, Miao LL, Thomas P, et al. Enhanced cyclooxygenase-2 gene expression in alcoholic liver disease in the rat[J].Gastroenterology, 1997,112(6): 943-951.
9[11]Tabernero A,Schneider F,Potenza MA,et al. Cyclooxygenase2 and inducible nitric oxide synthase in omental arteries harvested from patients with severe liver diseases:immuno-localization and influence on vascular tone[J]. Intensive Care Med,2003,29(3): 262-270.
10[12]Izutani R,Loh EY,Reinecker H,et al. Increased expression of interleukin-8 mRNA in ulcerative colitis and Crohn's disease mucosa and epithelial cell[J]. Inflammatory Bowel Dis, 1995,1(1):37-47.
7Perrone G, Santini D, Vincenzi B, et al. COX-2 expression in DCIS: Correlation with VEGF, HER-2/neu, prognostic molecular markers and clinicopathological features. Histopathology, 2005, 46 (5) : 561- 568.
8Frierson HF Jr, Wolber RA, Berean KW, et al. Interobserver reproducibility of the nottingham modification of the bloom and richardson histologic grading scheme for infiltrating ductal carcinoma. Am J Clin Pathol,1995, 103(2) :195-198.
9Oliveira VM, Piato S, Silva MA. Correlation of COX-2 and aromatase immunohistochemical expression in invasive ductal carcinoma, ductal carcinoma in situ, and adjacent normal epithelium. Breast Cancer Res Treat, 2006, 95(3):235-241.
10Tan KB, Yong WP, Putti TC. COX-2 expression: a potential prognostic and predictive marker for high-grade ductal carcinoma in situ of the breast. Histopathology, 2004, 44 ( 1 ) :24-28.
